Long term impact of 3‐monthly paliperidone palmitate on hospitalisation in patients with schizophrenia: Six‐year mirror image study
Article in Acta Psychiatrica Scandinavica (April 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Aripiprazole 2-month ready-to-use 960 mg (Ari 2MRTU): review of its possible role in schizophrenia therapy
Article in Current Medical Research and Opinion (December 2023)
Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal
Article in Drug Healthcare and Patient Safety (September 2023)